The following primary antibodies were used: mouse monoclonal antibodies to α-tubulin (clone DM1A, IgG1, Invitrogen); β-tubulin (clone TBN06, Invitrogen); h-β-I-tubulin (IgG2b, R&D Systems, Minneapolis, MN, USA); h-β-III-tubulin (IgG2a, R&D Systems); pan-actin (clone C4, Cell Signaling Technology Inc., Danvers, MA, USA);
β-actin (IgG1, MCA5775GA, AbD Serotec, Kidlington, UK); γ-actin (IgG2b, (MCA5776GA, AbD Serotec);
β-catenin (IgG1, DAKO, Glostrup, Denmark);
E-cadherin (IgG2a, BD Transduction);
MDR-1 (Santa Cruz Biotechnology, Dallas, TX, USA);
N-cadherin (Cell Signaling Technology Inc., Danvers, MA, USA);
claudin-1 (Cell Signaling Technology Inc.); and
vimentin (V9, DAKO).
The following secondary antibodies were used:
AlexaFluor488-,
Red-X,
AlexaFluor594-conjugated goat anti-mouse IgG or specific to IgG1, IgG2b, IgG2a, absorbed to other IgG isotypes, and
goat anti-rabbit IgG (Jackson ImmunoResearch Laboratories Inc., West Grove, PA, USA).
DAPI (D9542, Sigma-Aldrich) was applied for DNA (nuclear) staining. HRP-conjugated secondary antibodies were used for Western blot analysis:
anti-mouse IgG and
anti-rabbit IgG (Santa Cruz Biotechnology).
Dugina V., Vasileva M., Khromova N., Vinokurova S., Shagieva G., Mikheeva E., Galembikova A., Dunaev P., Kudlay D., Boichuk S, & Kopnin P. (2024). Imbalance between Actin Isoforms Contributes to Tumour Progression in Taxol-Resistant Triple-Negative Breast Cancer Cells. International Journal of Molecular Sciences, 25(8), 4530.